Prion infectivity in the spleen of a PRNP heterozygous individual with subclinical variant Creutzfeldt-Jakob disease

Brain

Volumn 136, Issue 4, 2013, Pages 1139-1145

  Bishop, Matthew T ^a   Diack, Abigail B ^b   Ritchie, Diane L ^a   Ironside, James W ^a   Will, Robert G ^a   Manson, Jean C ^b  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

blood transfusion; infection; prion; subclinical; variant Creutzfeldt Jakob disease

Indexed keywords

METHIONINE; PRION PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD DONOR; BLOOD TRANSFUSION; BRAIN HOMOGENATE; BRAIN SPONGIOSIS; BRAIN TISSUE; CODON; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE TRANSMISSION; ERYTHROCYTE; GENOTYPE; HETEROZYGOSITY; HOMOZYGOTE; IMMUNOCYTOCHEMISTRY; INCUBATION TIME; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SPLEEN; VARIANT CREUTZFELDT JAKOB DISEASE;

EID: 84876014342     PISSN: 00068950     EISSN: 14602156     Source Type: Journal    
DOI: 10.1093/brain/awt032     Document Type: Article

References (21)

1. Bishop MT, Hart P, Aitchison L, Baybutt HN, Plinston C, Thomson V, et al. Predicting susceptibility and incubation time of human-to-human transmission of vCJD. Lancet Neurol 2006; 5: 393-8.
2. Brown DA, Bruce ME, Fraser JR. Comparison of the neuropathological characteristics of bovine spongiform encephalopathy (BSE) and variant Creutzfeldt-Jakob disease (vCJD) in mice. Neuropathol Appl Neurobiol 2003; 29: 262-72.
3. Bruce ME, Boyle A, McConnel I. TSE strain typing in mice. In: Lehmann S, Grassi J, editors. Techniques in prion research. Birkhauser Verlag; 2004 p. 132-46.
4. Bruce ME, McConnell I, Will RG, Ironside JW. Detection of variant Creutzfeldt-Jakob disease infectivity in extraneural tissues. Lancet 2001; 358: 208-9.
5. Bruce ME, Will RG, Ironside JW, McConnell I, Drummond D, Suttie A, et al. Transmissions to mice indicate that new variant CJD is caused by the BSE agent. Nature 1997; 389: 498-501.
6. Clarke P, Will RG, Ghani AC. Is there the potential for an epidemic of variant Creutzfeldt-Jakob disease via blood transfusion in the UK? J R Soc Interface 2007; 4: 675-84.
7. Diack AB, Ritchie D, Bishop M, Pinion V, Brandel JP, Haik S, et al. Constant transmission properties of variant Creutzfeldt-Jakob disease in 5 countries. Emerg Infect Dis 2012; 18: 1574-9.
8. Fraser H, Dickinson AG. The sequential development of the brain lesion of scrapie in three strains of mice. J Comp Pathol 1968; 78: 301-11.
9. Garske T, Ghani AC. Uncertainty in the tail of the variant Creutzfeldt-Jakob disease epidemic in the UK. PLoS One 2010; 5: e15626.
10. Head MW, Bunn TJ, Bishop MT, McLoughlin V, Lowrie S, McKimmie CS, et al. Prion protein heterogeneity in sporadic but not variant Creutzfeldt-Jakob disease: UK cases 1991-2002. Ann Neurol 2004; 55: 851-9.
11. Hill AF, Desbruslais M, Joiner S, Sidle KC, Gowland I, Collinge J, et al. The same prion strain causes vCJD and BSE. Nature 1997; 389: 448-50.
12. Hilton DA, Ghani AC, Conyers L, Edwards P, McCardle L, Ritchie D, et al. Prevalence of lymphoreticular prion protein accumulation in UK tissue samples. J Pathol 2004; 203: 733-9.
13. HPA. Summary results of the second national survey of abnormal prion prevalence in archived appendix specimens. Health Prot Rep 2012; 6.
14. Llewelyn CA, Hewitt PE, Knight RS, Amar K, Cousens S, Mackenzie J, et al. Possible transmission of variant Creutzfeldt-Jakob disease by blood transfusion. Lancet 2004; 363: 417-21.
15. Peden AH, Head MW, Ritchie DL, Bell JE, Ironside JW. Preclinical vCJD after blood transfusion in a PRNP codon 129 heterozygous patient. Lancet 2004; 364: 527-9.
16. Pocchiari M, Puopolo M, Croes EA, Budka H, Gelpi E, Collins S, et al. Predictors of survival in sporadic Creutzfeldt-Jakob disease and other human transmissible spongiform encephalopathies. Brain 2004; 127: 2348-59.
17. Prusiner SB. Prions. Proc Natl Acad Sci USA 1998; 95: 13363-83.
18. Ritchie DL, Boyle A, McConnell I, Head MW, Ironside JW, Bruce ME. Transmissions of variant Creutzfeldt-Jakob disease from brain and lymphoreticular tissue show uniform and conserved bovine spongiform encephalopathy-related phenotypic properties on primary and secondary passage in wild-type mice. J Gen Virol 2009; 90 (Pt 12): 3075-82.
19. Wadsworth JD, Dalmau-Mena I, Joiner S, Linehan JM, OMalley C, Powell C, et al. Effect of fixation on brain and lymphoreticular vCJD prions and bioassay of key positive specimens from a retrospective vCJD prevalence study. J Pathol 2011; 223: 511-8.
20. Will RG, Ironside JW, Zeidler M, Cousens SN, Estibeiro K, Alperovitch A, et al. A new variant of Creutzfeldt-Jakob disease in the UK. Lancet 1996; 347: 921-5.
21. Wroe SJ, Pal S, Siddique D, Hyare H, Macfarlane R, Joiner S, et al. Clinical presentation and pre-mortem diagnosis of variant Creutzfeldt-Jakob disease associated with blood transfusion: a case report. Lancet 2006; 368: 2061-7.